Financials

  • Market Capitalization 3.18 B
  • Employee 145
  • Founded 2015
  • CEO N/A
  • Website www.ideayabio.com
  • Headquarter Delaware, United States
  • FIGI BBG00CTZ4D83
  • Industry Biotecnologia
Ricavi totali
Utile netto
Utile base per azione (EPS base)
Debito totale
Liquidità libera
Disponibilità liquide e mezzi equivalenti
Rapporto prezzo/utili
-27.01
Rapporto prezzo/fatturato
13.99

Related tickers

#NomePrezzo24h %7d %1M %1Y %Valore di MercatoUltimi 7 Giorni
1641
RARE
Ultragenyx Pharmaceutical Inc. - Common Stock
33.22 USD-1.77%-7.54%+34.93%+13.22%3.27 B USD
1661
BEAM
Beam Therapeutics Inc. - Common Stock
31.00 USD-5.14%-15.07%+3.85%+45.27%3.19 B USD
1679
ELVN
Enliven Therapeutics, Inc. - Common Stock
50.87 USD-0.43%+1.27%+11.48%+146.22%3.10 B USD
1701
CLDX
Celldex Therapeutics, Inc. - Common Stock
38.53 USD-1.48%+1.39%+21.47%+41.45%3.02 B USD

Notizie